You are here
News
November 1, 2013
PEPFAR's Impact After 10 Years
Launched in 2003, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest effort by any nation to combat a single disease. PEPFAR, which began as an emergency response to AIDS in low-resource settings, is now focused on advancing the sustainability of the response. The program directly supports more than 5 million people on antiretroviral treatment—up from 1.7 million in...
October 24, 2013
Researchers Design Global HIV Vaccine that Shows Promise in Early Studies
The worldwide diversity of HIV poses a critical challenge for designing a globally-effective HIV vaccine. In a new study published October 24 in the journal Cell, a scientific team has shown that bioinformatically optimized HIV vaccine antigens known as “mosaic” antigens might be useful in the design of a global HIV vaccine.
“In this study, we show for the first time that...
October 2, 2013
New Study, RV306, Begins Screening in Thailand
This study is the second RV144 Follow-up Immunogenicity Study
MHRP initiated several follow-on clinical studies to conduct intensive immunogenicity research on the RV144 vaccine regimen that are funded by NIAID and the U.S. Army. The data from these studies are informing future clinical research by providing insights into the immune mechanisms generated by the RV144 regimen and the...
September 27, 2013
MHRP at AIDS Vaccine 2013
AIDS Vaccine, the annual scientific conference dedicated to AIDS vaccine research, will be held in Barcelona this October and will draw thousands of the best scientific minds in the field of HIV research. If you are attending, be sure to check out the MHRP presentations and RV144-related presentations by collaborating organizations. See the schedule below:
Tuesday, October 8
...
September 20, 2013
MHRP Profiles
Meet Dr. Francis Kiweewa: AFRICOS Site Investigator at the Makerere University Walter Reed Project, Uganda
Dr. Francis Kiweewa is an experienced research physician who has a special interest in HIV and how it interacts with health systems. Dr. Kiweewa’s research has focused on the evaluation of HIV treatment options including regimens for first and second-line HIV treatment and the...
September 12, 2013
New Program in Tanzania Aims to Respond to and Reduce Gender Based Violence
The Southern Highlands region of Tanzania experiences one of the highest HIV prevalence rates in the country. The epidemic in this area is fueled in part by a societal acceptance of gender-based violence, which limits a woman’s ability to negotiate safe sexual practices. In Mbeya specifically, more than 67% of women have experienced some form of partner violence, which is higher compared to...
August 29, 2013
Thai Government To Support HIV Vaccine Study
The Ministry of Public Health and the Ministry of Science and Technology of the Kingdom of Thailand announced their commitment to build on the success of the landmark RV144 Thai HIV vaccine study. The announcement was made at the AIDS Vaccine Efficacy Consortium (AVEC) Summit for an AIDS-Free Generation in Thailand on August 29, 2013.
An HIV vaccine efficacy trial conducted in Thailand...
June 19, 2013
MHRP Deputy Col. Jerome Kim Receives Award for Research Excellence
MHRP Principal Deputy Col. Jerome Kim has won the 2013 John Maher Award for Research Excellence from the Department of Medicine at the Uniformed Services University (USU). The award recognizes Col. Kim's role in the 2012 NEJM publication describing the analysis of immunological correlates from the RV144 trial, along with his contributions to the USU Department of Medicine, where he is a...
May 20, 2013
New TB Lab Accredited in Tanzania
U.S. Ambassador to Tanzania Alfonso E. Lenhardt recently visited MHRP’s site, Walter Reed Program-Tanzania, to inaugurate a new specialized Tuberculosis (TB) laboratory at the Mbeya Referral Hospital (MRH). This is the second laboratory in the country of this kind.
TB remains a major global health problem. Thousands of Tanzanians are affected by tuberculosis each year and it ranks as...
May 17, 2013
Moving Forward this HIV Vaccine Awareness Day
A Statement from MHRP Director, Col. Nelson Michael
“It will take 10 years.” That is what researchers usually say when asked how much longer it will take to develop a safe and effective HIV vaccine.
Some of the world’s brightest minds have been on this quest for 30 years, yet we still do not have an HIV vaccine to use today. Recent clinical trials, such as the HVTN 505 study that...